Showing 1221-1230 of 6036 results for "".
Alcon Acquires LumiThera
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-acquires-lumithera/37092/Alcon makes a major acquisition to bolster is vitreoretinal surgery portfolio; the European Commission (EC) approves Eylea 8 mg for extended treatment intervals; and Eric Donnenfeld, MD, discusses the business of myopia management. Learn more about your ad choices. Visit megaphone.fm/adchoicesSpecial Report: Update on Holland Foundation
https://modernod.com/podcasts/eyewire-news-the-podcast/special-report-update-on-holland-foundation/37090/The leaders of the Holland Foundation provide an update on the progress of the foundation and its mission to restore sight for patients with Severe Ocular Surface Disease. Learn more about your ad choices. Visit megaphone.fm/adchoicesOcular Rheumatology
https://modernod.com/topics/ocular-surface/ocular-rheumatology/38988/Understand how systemic autoimmune disease can affect the eye and how to manage these complications.The Aesthetic Impact of OSD
https://modernod.com/topics/ocular-surface/the-aesthetic-impact-of-osd/38982/And the in-office treatments that address both ocular surface health and cosmetic concerns.Special Report: Executives Discuss Overcoming Challenges
https://modernod.com/podcasts/eyewire-news-the-podcast/special-report-executives-discuss-overcoming-challenges/37086/Ophthalmology executives share challenging situations they encountered, as well as the steps needed to overcome the challenge. Learn more about your ad choices. Visit megaphone.fm/adchoicesBreaking News from the ASCRS Meeting in Los Angeles
https://modernod.com/podcasts/eyewire-news-the-podcast/breaking-news-from-the-ascrs-meeting-in-los-angeles/37082/EyewireTV reports on new products and breaking news live from the American Society of Cataract and Refractive Surgery (ASCRS) meeting in Los Angeles. Learn more about your ad choices. Visit megaphone.fm/adchoicesFDA Issues CRL to Regeneron for Eylea HD Extended Dosing
https://modernod.com/podcasts/eyewire-news-the-podcast/fda-issues-crl-to-regeneron-for-eylea-hd-extended-dosing/37081/The FDA responds to Regeneron’s request to extend dosing intervals for Eylea HD; Regeneron applies for a new indication for Eylea HD; and several recent executive appointments are announced in the ophthalmology industry. Learn more about your ad choices. Visit megaphone.fm/adchoicesOrasis Launches Presbyopia Eye Drop Qlosi
https://modernod.com/podcasts/eyewire-news-the-podcast/orasis-launches-presbyopia-eye-drop-qlosi/37080/A presbyopia drop is officially launched in the US; Nordic Pharma receives European approval for its novel dry eye therapy; and Tenpoint submits an NDA for a presbyopia eye drop candidate. Learn more about your ad choices. Visit megaphone.fm/adchoicesUtilizing AI to Provide DR Screening to Underserved Communities
https://modernod.com/podcasts/eyewire-news-the-podcast/utilizing-ai-to-provide-dr-screening-to-underserved-communities/37079/EyewireTV speaks with the leaders of Digital Diagnostics and AEYE Health about their diabetic screening technology, racial and socioeconomic disparities in eye care, and their mission to improve health equity by expanding their technology into underserved populations. Learn more about your ad choiceFDA Approves First Treatment for MacTel
https://modernod.com/podcasts/eyewire-news-the-podcast/fda-approves-first-treatment-for-mactel/37075/The CEO of Neurotech joins us to talk about the FDA approval of the first treatment for MacTel; a target action date is set for Sydnexis’ pediatric myopia treatment candidate; and three eye care companies collaborate to launch a wearable vision testing platform. Learn more about your ad choices. Vis